17-3723958-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_031965.2(HASPIN):​c.23C>T​(p.Pro8Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000141 in 1,417,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

HASPIN
NM_031965.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.122
Variant links:
Genes affected
HASPIN (HGNC:19682): (histone H3 associated protein kinase) Enables ATP binding activity and histone kinase activity (H3-T3 specific). Involved in histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore; intracellular signal transduction; and mitotic sister chromatid cohesion. Located in centrosome; nucleoplasm; and spindle. [provided by Alliance of Genome Resources, Apr 2022]
ITGAE (HGNC:6147): (integrin subunit alpha E) Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. This gene encodes an I-domain-containing alpha integrin that undergoes post-translational cleavage in the extracellular domain, yielding disulfide-linked heavy and light chains. In combination with the beta 7 integrin, this protein forms the E-cadherin binding integrin known as the human mucosal lymphocyte-1 antigen. This protein is preferentially expressed in human intestinal intraepithelial lymphocytes (IEL), and in addition to a role in adhesion, it may serve as an accessory molecule for IEL activation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06739816).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HASPINNM_031965.2 linkuse as main transcriptc.23C>T p.Pro8Leu missense_variant 1/1 ENST00000325418.5 NP_114171.2 Q8TF76-1A0PJ70
ITGAENM_002208.5 linkuse as main transcriptc.3085-214G>A intron_variant ENST00000263087.9 NP_002199.3 P38570

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HASPINENST00000325418.5 linkuse as main transcriptc.23C>T p.Pro8Leu missense_variant 1/16 NM_031965.2 ENSP00000325290.4 Q8TF76-1
ITGAEENST00000263087.9 linkuse as main transcriptc.3085-214G>A intron_variant 1 NM_002208.5 ENSP00000263087.4 P38570
ITGAEENST00000570415.5 linkuse as main transcriptn.479-214G>A intron_variant 3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000474
AC:
1
AN:
210818
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
117612
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000342
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000141
AC:
2
AN:
1417096
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
700514
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000256
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.18e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33
ExAC
AF:
0.00000843
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 19, 2024The c.23C>T (p.P8L) alteration is located in exon 1 (coding exon 1) of the GSG2 gene. This alteration results from a C to T substitution at nucleotide position 23, causing the proline (P) at amino acid position 8 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
5.8
DANN
Benign
0.85
DEOGEN2
Benign
0.054
T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.36
T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.067
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.90
L
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.59
N
REVEL
Benign
0.042
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.017
D
Polyphen
0.0010
B
Vest4
0.15
MutPred
0.16
Loss of glycosylation at P8 (P = 0.018);
MVP
0.17
MPC
0.39
ClinPred
0.090
T
GERP RS
0.051
Varity_R
0.039
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs762347012; hg19: chr17-3627252; API